ADHD

Clinical trials for ADHD explained in plain language.

Never miss a new study

Get alerted when new ADHD trials appear

Sign up with your email to follow new studies for ADHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 23 Not yet recruiting 8 Not yet finished but already full! 7 Completed 18 Terminated 1

ADHD drug combo trial halted early

Disease control Terminated

This study aimed to see if adding a new medicine (NRCT-101SR) to a standard ADHD drug (NRCT-202XR) works better and is safe for teens. It planned to enroll about 60 teenagers (ages 13-17) with ADHD for a 6-week period. The trial was terminated early, with only 2 participants enro…

Matched conditions: ADHD

Phase: PHASE2 • Sponsor: Neurocentria, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ADHD

Get alerted when new ADHD trials appear

ADHD drug combo trial halted early